SPINT2

serine peptidase inhibitor, Kunitz type 2

Basic information

Region (hg38): 19:38244035-38292615

Links

ENSG00000167642NCBI:10653OMIM:605124HGNC:11247Uniprot:O43291AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • congenital secretory sodium diarrhea 3 (Strong), mode of inheritance: AR
  • congenital secretory sodium diarrhea 3 (Moderate), mode of inheritance: AR
  • congenital secretory sodium diarrhea 3 (Strong), mode of inheritance: AR
  • syndromic congenital sodium diarrhea (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diarrhea 3, secretory sodium, congenital, with or without other congenital anomaliesADGastrointestinalDue to fecal sodium loss, individuals may present with severe (potentially lethal) secretory diarrhea and related electrolyte/metabolic derangements, including hyponatremic metabolic acidosis, and recognition may allow appropriate medical management, which includes parenteral nutrition (weaning from parenteral nutrition, with oral sodium citrate supplementation, is possible in childhoodCraniofacial; Dermatologic; Gastrointestinal; Hematologic; Musculoskeletal; Ophthalmologic11113072; 17786112; 19185281; 20009592

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPINT2 gene.

  • not_provided (147 variants)
  • Inborn_genetic_diseases (25 variants)
  • Congenital_secretory_sodium_diarrhea_3 (15 variants)
  • SPINT2-related_disorder (7 variants)
  • Congenital_sodium_diarrhea (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPINT2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021102.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
45
clinvar
3
clinvar
48
missense
2
clinvar
3
clinvar
51
clinvar
5
clinvar
2
clinvar
63
nonsense
1
clinvar
1
start loss
3
3
frameshift
1
clinvar
1
clinvar
2
clinvar
4
splice donor/acceptor (+/-2bp)
3
clinvar
3
clinvar
1
clinvar
7
Total 10 7 54 50 5

Highest pathogenic variant AF is 0.00019660403

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPINT2protein_codingprotein_codingENST00000301244 748580
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0007510.9311257260221257480.0000875
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9971181530.7730.000009601631
Missense in Polyphen2536.7170.68088436
Synonymous0.4776064.90.9250.00000400517
Loss of Function1.61713.40.5236.84e-7145

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009050.0000905
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.0001490.000149
Middle Eastern0.0001090.000109
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Inhibitor of HGF activator. Also inhibits plasmin, plasma and tissue kallikrein, and factor XIa.;
Disease
DISEASE: Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies (DIAR3) [MIM:270420]: A disease characterized by life-threatening secretory diarrhea, severe metabolic acidosis and hyponatremia. Hyponatremia is secondary to extraordinarily high fecal sodium loss, with low or normal excretion of urinary sodium, in the absence of infectious, autoimmune and endocrine causes. {ECO:0000269|PubMed:19185281}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Signal Transduction;MET Receptor Activation;Signaling by MET;Signaling by MST1;Signaling by Receptor Tyrosine Kinases (Consensus)

Recessive Scores

pRec
0.335

Intolerance Scores

loftool
0.664
rvis_EVS
0.44
rvis_percentile_EVS
77.7

Haploinsufficiency Scores

pHI
0.100
hipred
N
hipred_score
0.210
ghis
0.406

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spint2
Phenotype
limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
neural tube closure;establishment or maintenance of cell polarity;negative regulation of endopeptidase activity;negative regulation of cell-cell adhesion;epithelial cell morphogenesis involved in placental branching;basement membrane organization;cellular response to BMP stimulus;negative regulation of cell motility;negative regulation of neural precursor cell proliferation
Cellular component
extracellular region;cytoplasm;plasma membrane;integral component of membrane
Molecular function
endopeptidase inhibitor activity;serine-type endopeptidase inhibitor activity